Dana Funding Advisors Inc. lowered its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.7% within the second quarter, in keeping with the corporate in its most up-to-date Kind 13F submitting with the Securities and Alternate Fee. The fund owned 47,751 shares of the corporate’s inventory after promoting 319 shares throughout the interval. Dana Funding Advisors Inc.’s holdings in Johnson & Johnson have been value $6,979,000 on the finish of the newest reporting interval.
A number of different institutional traders and hedge funds additionally not too long ago modified their holdings of JNJ. Innealta Capital LLC acquired a brand new stake in Johnson & Johnson throughout the 2nd quarter valued at $27,000. MFA Wealth Advisors LLC bought a brand new stake in Johnson & Johnson throughout the 2nd quarter value about $43,000. Vermillion & White Wealth Administration Group LLC acquired a brand new place in Johnson & Johnson within the 4th quarter valued at about $44,000. Fairfield Monetary Advisors LTD bought a brand new place in Johnson & Johnson within the 2nd quarter valued at about $46,000. Lastly, Grayhawk Funding Methods Inc. grew its holdings in shares of Johnson & Johnson by 528.6% throughout the fourth quarter. Grayhawk Funding Methods Inc. now owns 308 shares of the corporate’s inventory value $48,000 after shopping for a further 259 shares within the final quarter. Hedge funds and different institutional traders personal 69.55% of the corporate’s inventory.
Johnson & Johnson Value Efficiency
JNJ opened at $162.02 on Wednesday. The corporate has a 50 day transferring common of $162.50 and a two-hundred day transferring common of $154.21. The corporate has a fast ratio of 0.85, a present ratio of 1.07 and a debt-to-equity ratio of 0.44. Johnson & Johnson has a 52-week low of $143.13 and a 52-week excessive of $168.85. The corporate has a market cap of $389.93 billion, a P/E ratio of 10.10, a P/E/G ratio of two.69 and a beta of 0.53.
Johnson & Johnson (NYSE:JNJ – Get Free Report) final issued its quarterly earnings knowledge on Wednesday, July seventeenth. The corporate reported $2.82 EPS for the quarter, topping analysts’ consensus estimates of $2.71 by $0.11. The agency had income of $22.45 billion for the quarter, in comparison with analyst estimates of $22.33 billion. Johnson & Johnson had a internet margin of 46.34% and a return on fairness of 36.60%. The agency’s income was up 4.3% in comparison with the identical quarter final 12 months. Throughout the identical quarter within the earlier 12 months, the enterprise posted $2.80 EPS. On common, analysts anticipate that Johnson & Johnson will publish 10.02 earnings per share for the present 12 months.
Johnson & Johnson Publicizes Dividend
The corporate additionally not too long ago introduced a quarterly dividend, which was paid on Tuesday, September tenth. Shareholders of report on Tuesday, August twenty seventh have been issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized foundation and a yield of three.06%. The ex-dividend date was Tuesday, August twenty seventh. Johnson & Johnson’s dividend payout ratio is presently 30.92%.
Insider Transactions at Johnson & Johnson
In associated information, VP Robert J. Decker bought 5,635 shares of the agency’s inventory in a transaction on Friday, August thirtieth. The inventory was bought at a median worth of $165.06, for a complete transaction of $930,113.10. Following the transaction, the vp now immediately owns 18,973 shares within the firm, valued at $3,131,683.38. The sale was disclosed in a doc filed with the Securities & Alternate Fee, which is accessible by the SEC web site. Insiders personal 0.16% of the corporate’s inventory.
Analysts Set New Value Targets
A number of analysis companies have commented on JNJ. StockNews.com raised shares of Johnson & Johnson from a “purchase” score to a “strong-buy” score in a analysis be aware on Saturday, September 14th. Sanford C. Bernstein raised their worth goal on Johnson & Johnson from $161.00 to $171.00 in a report on Thursday, July 18th. TD Securities dropped their goal worth on Johnson & Johnson from $195.00 to $185.00 in a analysis be aware on Thursday, July 18th. Daiwa America lowered Johnson & Johnson from a “strong-buy” score to a “maintain” score in a analysis be aware on Tuesday, July twenty third. Lastly, The Goldman Sachs Group dropped their worth goal on shares of Johnson & Johnson from $160.00 to $155.00 and set a “impartial” score for the corporate in a analysis be aware on Friday, July nineteenth. Seven analysts have rated the inventory with a maintain score, six have assigned a purchase score and one has given a robust purchase score to the corporate. In response to MarketBeat, the inventory at the moment has a median score of “Reasonable Purchase” and a median worth goal of $173.21.
View Our Newest Inventory Report on Johnson & Johnson
About Johnson & Johnson
Johnson & Johnson, along with its subsidiaries, researches, develops, manufactures, and sells numerous merchandise within the healthcare area worldwide. The corporate’s Modern Drugs phase provides merchandise for numerous therapeutic areas, akin to immunology, together with rheumatoid arthritis, psoriatic arthritis, inflammatory bowel illness, and psoriasis; infectious ailments comprising HIV/AIDS; neuroscience, consisting of temper problems, neurodegenerative problems, and schizophrenia; oncology, akin to prostate most cancers, hematologic malignancies, lung most cancers, and bladder most cancers; cardiovascular and metabolism, together with thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension by retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
See Additionally
Need to see what different hedge funds are holding JNJ? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).
Obtain Information & Rankings for Johnson & Johnson Day by day – Enter your e-mail deal with under to obtain a concise each day abstract of the most recent information and analysts’ scores for Johnson & Johnson and associated corporations with MarketBeat.com’s FREE each day e-mail publication.
